ML290 is a biased allosteric agonist at the relaxin receptor RXFP1. - Wikidata - wikimedia - TriplyDB

ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.

ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.

http://www.wikidata.org/entity/Q33774441

about

Heart Disease and Relaxin: New Actions for an Old Hormone.Real-time examination of cAMP activity at relaxin family peptide receptors using a BRET-based biosensor

P2860

Q52662132-96A8C729-FD55-43CD-BAE8-848917FA7A86 Q58701291-23D60FCF-60B4-4382-A70F-6BD89CA1B006

P2860

ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.

http://www.wikidata.org/entity/Q33774441

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.

@ast

ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.

@en

type

label

ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.

@ast

ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.

@en

prefLabel

ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.

@ast

ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.

@en

P1433

Q33774441-E208418D-88C9-4B89-A6C5-4B501F6B7D74

P1476

Q33774441-B8CC0970-8BA9-4CA9-8A7B-A830C598A0E0

P2093

Q33774441-343F7266-71D6-4716-9F45-6775463AB189

Q33774441-494E67AC-89D3-4588-887F-931C5282E9E8

Q33774441-4CD2FB68-4F7B-4C3E-8C3A-02D99D2CD28F

Q33774441-54AC1C6D-7283-46A6-B3D6-D6C849F99019

Q33774441-8FBCF493-EE94-4FE1-B4C9-A99CF1B47B1C

Q33774441-C2ED106B-CB26-46C3-8216-2BC0510C7DCE

Q33774441-D8261893-3B8D-4CB6-9D47-A420A817AFAB

P2860

Q33774441-03E4E133-DD11-4AF1-9F74-9B8F356F4B7E

Q33774441-0B692782-17A3-412E-B3A6-3D9278C37894

Q33774441-0D1CA85D-405A-49D7-AA63-92FE692D793F

Q33774441-1205A4F2-2D29-4703-A8D4-1F102E3E7BCA

Q33774441-12A054AE-9DE1-4F31-98BF-F0219861AB41

Q33774441-192D7F92-156E-4972-8C73-714420A9B8EA

Q33774441-1A9522C3-DA97-446E-84E9-59FC67446548

Q33774441-23765233-0D2E-4FDE-A28A-204BE2E4920C

Q33774441-29832357-F12D-4D1A-B9EB-89A0EF7B9C74

Q33774441-2BC8D38D-07B1-48B0-8FC3-E3B89BAFE50C

P2888

Q33774441-E0416682-47C1-4B36-99A6-F748C209A519

P304

Q33774441-F4F9CABF-C584-457B-9817-042A15968CE3

P31

Q33774441-BF61C9FF-7693-478F-B9F6-E4FD18ABA86A

P356

Q33774441-FEBEF575-EAE4-45E2-A8AD-6E7502F9A0E3

P407

Q33774441-C8EC89AA-CD33-4413-A9DD-592BC9181E0C

P433

Q33774441-BD38A55D-0C43-4DE2-A407-66DCD246BDEE

P478

Q33774441-D78815A3-CCB8-49F1-B448-E453E93D8944

P50

Q33774441-2F5760E8-3905-4573-9355-0B7D7B4E5D6F

Q33774441-3866D848-78A2-4FCF-A41D-C0DBCA9D61C1

Q33774441-49C1A299-12F7-440F-B108-0B99F49C6DDA

Q33774441-A1C6ED15-D2BE-476C-9A46-158C0CDC1FF6

Q33774441-EC563B4B-01B3-4B13-977F-2F4F2333A575

Q33774441-F576F2A9-B232-425A-81B3-1D5BB6A8B78C

P577

Q33774441-9B06FC85-2090-41C1-A540-EF7C72625BBA

P6179

Q33774441-871F1644-5946-447B-AA50-0179E86D709F

P698

Q33774441-23DC442C-B836-406A-A87A-67D477F21F5D

P932

Q33774441-078BA975-74D6-41E0-947B-567855A27D2E

P356

S41598-017-02916-5

P1433

Scientific Reports

P1476

ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.

@en

P2093

Alexander I Agoulnik

http://www.w3.org/2001/XMLSchema#string

Chrishan S Samuel

http://www.w3.org/2001/XMLSchema#string

Jingbo Xiao

http://www.w3.org/2001/XMLSchema#string

Juan J Marugan

http://www.w3.org/2001/XMLSchema#string

Mohsin Sarwar

http://www.w3.org/2001/XMLSchema#string

Ross A D Bathgate

http://www.w3.org/2001/XMLSchema#string

Sheng Y Ang

http://www.w3.org/2001/XMLSchema#string

P2860

Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms

The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation

The trap-like relaxin-binding site of the leucine-rich G-protein-coupled receptor 7

Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2

The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.

Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3)

Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.

Investigation of interactions at the extracellular loops of the relaxin family peptide receptor 1 (RXFP1).

P2888

s41598-017-02916-5

P304

2968

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-02916-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Roger J. Summers

Dana S Hutchinson

Mohammed Akhter Hossain

P577

2017-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085793349

http://www.w3.org/2001/XMLSchema#string

P698

28592882

http://www.w3.org/2001/XMLSchema#string

P932

5462828

http://www.w3.org/2001/XMLSchema#string